trial
as of 2026-07-01Anticholinergic Burden in Schizophrenia
NCTId NCT00715377
at a glance
— · Terminated
Enrollment 2 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2011-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Terminated
Enrollment
2 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2007-06
Primary completion
2011-12
Eligibility
ALL · 50 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
Ariel Graff, MD, PhDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
2
Phase
NA
Primary Completion Date
2011-12
Status
TERMINATED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person